eif4e Search Results


94
Novus Biologicals anti eif4e
Anti Eif4e, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eif4e/Human%2FMouse%2FRat+eIF4E+Antibody/bio_rxiv__2020__07__13__199828-141-126-127
Average 94 stars, based on 1 article reviews
anti eif4e - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc phospho eif4e
Phospho Eif4e, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eif4e/Phospho-eIF4E+(Ser209)+Antibody/pmc03970741-34-16-25
Average 96 stars, based on 1 article reviews
phospho eif4e - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc eif4e
FIG. 4. Amino acid starvation changes the levels of phospho- rylated <t>eIF4E</t> and eIF2a. C6 cells were incubated in amino acid-fed (Fed) or amino acid-starved (Starved) conditions or in the presence of rapamycin (Rap; 50 ng/ml) for 12 h (A) or for the time indicated (B). Western blots of whole cell lysates (15 mg of protein) were probed for eIF2a, phospho-eIF2a, eIF4E, and phospho-eIF4E.
Eif4e, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eif4e/eIF4E+Antibody/10__1074_slash_jbc__m009714200-67-11-15
Average 96 stars, based on 1 article reviews
eif4e - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

93
Addgene inc ubiquitin c ubc promoter
FIG. 4. Amino acid starvation changes the levels of phospho- rylated <t>eIF4E</t> and eIF2a. C6 cells were incubated in amino acid-fed (Fed) or amino acid-starved (Starved) conditions or in the presence of rapamycin (Rap; 50 ng/ml) for 12 h (A) or for the time indicated (B). Western blots of whole cell lysates (15 mg of protein) were probed for eIF2a, phospho-eIF2a, eIF4E, and phospho-eIF4E.
Ubiquitin C Ubc Promoter, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eif4e/%5BUBC%5D%5BEIF4e%5D%5BGG+cloning%5D+(Plasmid+%2397189)/pmc07791524-70-8-12
Average 93 stars, based on 1 article reviews
ubiquitin c ubc promoter - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

93
Addgene inc paav ef1α inteinc crec plasmids
FIG. 4. Amino acid starvation changes the levels of phospho- rylated <t>eIF4E</t> and eIF2a. C6 cells were incubated in amino acid-fed (Fed) or amino acid-starved (Starved) conditions or in the presence of rapamycin (Rap; 50 ng/ml) for 12 h (A) or for the time indicated (B). Western blots of whole cell lysates (15 mg of protein) were probed for eIF2a, phospho-eIF2a, eIF4E, and phospho-eIF4E.
Paav Ef1α Inteinc Crec Plasmids, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eif4e/MSCV+eIF4E+IRES+GFP+(Plasmid+%2318761)/pmc09641071-267-5-11
Average 93 stars, based on 1 article reviews
paav ef1α inteinc crec plasmids - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

93
Proteintech eif4e2
FIG. 4. Amino acid starvation changes the levels of phospho- rylated <t>eIF4E</t> and eIF2a. C6 cells were incubated in amino acid-fed (Fed) or amino acid-starved (Starved) conditions or in the presence of rapamycin (Rap; 50 ng/ml) for 12 h (A) or for the time indicated (B). Western blots of whole cell lysates (15 mg of protein) were probed for eIF2a, phospho-eIF2a, eIF4E, and phospho-eIF4E.
Eif4e2, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eif4e/EIF4E2+Antibody/ppr0613601-214-33-37
Average 93 stars, based on 1 article reviews
eif4e2 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

93
Proteintech ngdn
FIG. 4. Amino acid starvation changes the levels of phospho- rylated <t>eIF4E</t> and eIF2a. C6 cells were incubated in amino acid-fed (Fed) or amino acid-starved (Starved) conditions or in the presence of rapamycin (Rap; 50 ng/ml) for 12 h (A) or for the time indicated (B). Western blots of whole cell lysates (15 mg of protein) were probed for eIF2a, phospho-eIF2a, eIF4E, and phospho-eIF4E.
Ngdn, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eif4e/NGDN+Antibody/pm28976967-317-11-22
Average 93 stars, based on 1 article reviews
ngdn - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

95
Proteintech 4ebp1
FIG. 4. Amino acid starvation changes the levels of phospho- rylated <t>eIF4E</t> and eIF2a. C6 cells were incubated in amino acid-fed (Fed) or amino acid-starved (Starved) conditions or in the presence of rapamycin (Rap; 50 ng/ml) for 12 h (A) or for the time indicated (B). Western blots of whole cell lysates (15 mg of protein) were probed for eIF2a, phospho-eIF2a, eIF4E, and phospho-eIF4E.
4ebp1, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eif4e/4EBP1+Antibody/ppr0577598-38-29-34
Average 95 stars, based on 1 article reviews
4ebp1 - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology anti eif4e antibody
12/15-LOX is required for TXA2-induced platelet activation and hemostasis (A–C) Eight-weeks-old WT and 12/15-LOX −/− mice were subjected to measurement of body weight (A), tail bleeding time (B), and whole blood clotting time (C) ( n = 10). (D) Platelet-rich plasma (PRP) from WT and 12/15-LOX −/− mice were incubated with and without F 2 -TXA2 (1 μM) for the indicated periods at RT and photographed. The percentage of clot retraction and extruded serum volume were calculated as described in the methods ( n = 3). (E) Wahed platelets were plated onto fibrinogen-coated coverslips and after 1 h stained with phalloidin and DAPI and observed under a Zeiss inverted microscope (Axiovision Observer.z1; 40×/NA 0.6). The pictures were captured by a Zeiss AxioCam MRm camera using the microscope operating and image analysis software ZEN 2.6. (F) Washed platelets from WT mice were labeled with calcein acetoxymethyl ester (10 μM) for 30 min and placed onto fibrinogen-coated wells in a 96-well plate. Platelets were then incubated with and without F 2 -TXA2 at the indicated concentrations for 30 min, washed with PBS and the bound platelets were lysed with lysis buffer and the fluorescence intensity was measured at 494 excitation and 517 emission ( n = 3). (G) PRP from WT mice treated with and without F 2 -TXA2 at the indicated concentrations was subjected to aggregation assay in an aggregometer ( n = 3). (H) Washed platelets from WT and 12/15-LOX −/− mice were subjected adhesion assay as shown in panel F ( n = 3). (I) PRP from WT and 12/15-LOX −/− mice with and without the indicated treatments were subjected to aggregation assay in an aggregometer ( n = 3). (J) Washed platelets from WT and 12/15-LOX −/− mice were incubated with and without F 2 -TXA2 for 30 min and plated onto fibrinogen-coated coverslips for 1 h. Platelets were then fixed, permeabilized, and stained with phalloidin to visualize F-actin, and pictures were captured. (K and L) Platelets from WT and 12/15-LOX −/− mice were incubated with and without F 2 -TXA2 (1 μM) for indicated time periods, and RNA and protein extracts were prepared and analyzed by qRT-PCR (K) and western blotting (L) for 12-LOX, 12/15-LOX and β-actin mRNA and protein levels using their specific primers or antibodies, respectively ( n = 3). (M) Platelets from WT and 12/15-LOX −/− mice were treated with and without F 2 -TXA2 for 30 min, and protein extracts were prepared and analyzed by western blotting for the levels of phospho and total <t>eIF4E</t> and 4EBP1 using their specific antibodies ( n = 3). (N) All the conditions were the same as in panel M except that the extracts were immunoprecipitated with anti-4EBP1 antibody, and the immunocomplexes were analyzed by western blotting for eIF4E and normalized for 4EBP1. The input protein was analyzed for β-actin levels. (O and P) Platelets from WT mice were incubated with and without F 2 -TXA2 in the presence and absence of rapamycin (100 nM) or torin1 (100 nM) for 30 min, and protein extracts were analyzed by western blotting for p4EBP1, 4EBP1, 12/15-LOX, and β-actin levels using their specific antibodies ( n = 3). (Q) Platelets from WT mice and 12/15-LOX −/− mice were assessed for 12(S)-HETE levels using a kit from Cayman ( n = 7). (R–W) Platelets from WT mice and 12/15-LOX −/− mice were treated with and without U46619 (1 μM) or ADP (40 μM) for 30 min and 12(S)-HETE levels were measured (R and U) ( n = 7) or subjected to adhesion assay (S and V) ( n = 3) or aggregation assay (T and W) ( n = 3). All data are presented as mean ± SD and analyzed by paired Student’s t test. ∗ p < 0.01 versus WT mice or control; # p < 0.01 versus F 2 -TXA2 or WT + F 2 -TXA2 or U46619. Scale bars: 10 μm in (E) and (J).
Anti Eif4e Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eif4e/eIF4E+Antibody/pmc12914311-23-0-3
Average 96 stars, based on 1 article reviews
anti eif4e antibody - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

95
Santa Cruz Biotechnology eif4e
Figure 3. <t>eIF4E</t> is required for MCT-1 interaction with the cap complex. The eIF4E was immunodepleted from the reticulocyte lysate containing the MCT-1 and MCT-1 deletion proteins. A, Western blot with eIF4E antibody of the lysate before and after eIF4E depletion as well as the depleted eIF4E. B, the cap binding assay was done as in Fig. 2B, but also with the eIF4E-depleted extract (left). Right, 5% of the input MCT-1 and deletion proteins. C, MCT-1 and DENR sediment with the translation initiation complex. Transiently transfected 293HEK cells were used for polysome preparation as described. Fractions 1 to 3 are typically completely devoid of ribosome components and contain multifactor complex. Representative polysome distribution profile (top). Representative Western blot analysis with antibodies against eIF2a, eIF4E, Myc-DENR, V5-MCT-1, h-actin, and rS6p (bottom).
Eif4e, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eif4e/eIF-4E/10__1158_slash_0008___5472__can___06___1999-75-12-20
Average 95 stars, based on 1 article reviews
eif4e - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier

93
Novus Biologicals his eif4e bait protein
Figure 3. <t>eIF4E</t> is required for MCT-1 interaction with the cap complex. The eIF4E was immunodepleted from the reticulocyte lysate containing the MCT-1 and MCT-1 deletion proteins. A, Western blot with eIF4E antibody of the lysate before and after eIF4E depletion as well as the depleted eIF4E. B, the cap binding assay was done as in Fig. 2B, but also with the eIF4E-depleted extract (left). Right, 5% of the input MCT-1 and deletion proteins. C, MCT-1 and DENR sediment with the translation initiation complex. Transiently transfected 293HEK cells were used for polysome preparation as described. Fractions 1 to 3 are typically completely devoid of ribosome components and contain multifactor complex. Representative polysome distribution profile (top). Representative Western blot analysis with antibodies against eIF2a, eIF4E, Myc-DENR, V5-MCT-1, h-actin, and rS6p (bottom).
His Eif4e Bait Protein, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eif4e/Recombinant+Human+eIF4E+His+Protein/pm36274088-338-4-7
Average 93 stars, based on 1 article reviews
his eif4e bait protein - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

Image Search Results


FIG. 4. Amino acid starvation changes the levels of phospho- rylated eIF4E and eIF2a. C6 cells were incubated in amino acid-fed (Fed) or amino acid-starved (Starved) conditions or in the presence of rapamycin (Rap; 50 ng/ml) for 12 h (A) or for the time indicated (B). Western blots of whole cell lysates (15 mg of protein) were probed for eIF2a, phospho-eIF2a, eIF4E, and phospho-eIF4E.

Journal: Journal of Biological Chemistry

Article Title: Internal Ribosome Entry Site-mediated Translation of a Mammalian mRNA Is Regulated by Amino Acid Availability

doi: 10.1074/jbc.m009714200

Figure Lengend Snippet: FIG. 4. Amino acid starvation changes the levels of phospho- rylated eIF4E and eIF2a. C6 cells were incubated in amino acid-fed (Fed) or amino acid-starved (Starved) conditions or in the presence of rapamycin (Rap; 50 ng/ml) for 12 h (A) or for the time indicated (B). Western blots of whole cell lysates (15 mg of protein) were probed for eIF2a, phospho-eIF2a, eIF4E, and phospho-eIF4E.

Article Snippet: Total and phosphorylated (Ser-209) eIF4E were detected using polyclonal antibodies for eIF4E and phospho-eIF4E, respectively (Cell Signaling).

Techniques: Incubation, Western Blot

12/15-LOX is required for TXA2-induced platelet activation and hemostasis (A–C) Eight-weeks-old WT and 12/15-LOX −/− mice were subjected to measurement of body weight (A), tail bleeding time (B), and whole blood clotting time (C) ( n = 10). (D) Platelet-rich plasma (PRP) from WT and 12/15-LOX −/− mice were incubated with and without F 2 -TXA2 (1 μM) for the indicated periods at RT and photographed. The percentage of clot retraction and extruded serum volume were calculated as described in the methods ( n = 3). (E) Wahed platelets were plated onto fibrinogen-coated coverslips and after 1 h stained with phalloidin and DAPI and observed under a Zeiss inverted microscope (Axiovision Observer.z1; 40×/NA 0.6). The pictures were captured by a Zeiss AxioCam MRm camera using the microscope operating and image analysis software ZEN 2.6. (F) Washed platelets from WT mice were labeled with calcein acetoxymethyl ester (10 μM) for 30 min and placed onto fibrinogen-coated wells in a 96-well plate. Platelets were then incubated with and without F 2 -TXA2 at the indicated concentrations for 30 min, washed with PBS and the bound platelets were lysed with lysis buffer and the fluorescence intensity was measured at 494 excitation and 517 emission ( n = 3). (G) PRP from WT mice treated with and without F 2 -TXA2 at the indicated concentrations was subjected to aggregation assay in an aggregometer ( n = 3). (H) Washed platelets from WT and 12/15-LOX −/− mice were subjected adhesion assay as shown in panel F ( n = 3). (I) PRP from WT and 12/15-LOX −/− mice with and without the indicated treatments were subjected to aggregation assay in an aggregometer ( n = 3). (J) Washed platelets from WT and 12/15-LOX −/− mice were incubated with and without F 2 -TXA2 for 30 min and plated onto fibrinogen-coated coverslips for 1 h. Platelets were then fixed, permeabilized, and stained with phalloidin to visualize F-actin, and pictures were captured. (K and L) Platelets from WT and 12/15-LOX −/− mice were incubated with and without F 2 -TXA2 (1 μM) for indicated time periods, and RNA and protein extracts were prepared and analyzed by qRT-PCR (K) and western blotting (L) for 12-LOX, 12/15-LOX and β-actin mRNA and protein levels using their specific primers or antibodies, respectively ( n = 3). (M) Platelets from WT and 12/15-LOX −/− mice were treated with and without F 2 -TXA2 for 30 min, and protein extracts were prepared and analyzed by western blotting for the levels of phospho and total eIF4E and 4EBP1 using their specific antibodies ( n = 3). (N) All the conditions were the same as in panel M except that the extracts were immunoprecipitated with anti-4EBP1 antibody, and the immunocomplexes were analyzed by western blotting for eIF4E and normalized for 4EBP1. The input protein was analyzed for β-actin levels. (O and P) Platelets from WT mice were incubated with and without F 2 -TXA2 in the presence and absence of rapamycin (100 nM) or torin1 (100 nM) for 30 min, and protein extracts were analyzed by western blotting for p4EBP1, 4EBP1, 12/15-LOX, and β-actin levels using their specific antibodies ( n = 3). (Q) Platelets from WT mice and 12/15-LOX −/− mice were assessed for 12(S)-HETE levels using a kit from Cayman ( n = 7). (R–W) Platelets from WT mice and 12/15-LOX −/− mice were treated with and without U46619 (1 μM) or ADP (40 μM) for 30 min and 12(S)-HETE levels were measured (R and U) ( n = 7) or subjected to adhesion assay (S and V) ( n = 3) or aggregation assay (T and W) ( n = 3). All data are presented as mean ± SD and analyzed by paired Student’s t test. ∗ p < 0.01 versus WT mice or control; # p < 0.01 versus F 2 -TXA2 or WT + F 2 -TXA2 or U46619. Scale bars: 10 μm in (E) and (J).

Journal: iScience

Article Title: Alox15 via H 2 O 2 mediates TP receptor palmitoylation and its membrane trafficking leading to platelet activation

doi: 10.1016/j.isci.2026.114796

Figure Lengend Snippet: 12/15-LOX is required for TXA2-induced platelet activation and hemostasis (A–C) Eight-weeks-old WT and 12/15-LOX −/− mice were subjected to measurement of body weight (A), tail bleeding time (B), and whole blood clotting time (C) ( n = 10). (D) Platelet-rich plasma (PRP) from WT and 12/15-LOX −/− mice were incubated with and without F 2 -TXA2 (1 μM) for the indicated periods at RT and photographed. The percentage of clot retraction and extruded serum volume were calculated as described in the methods ( n = 3). (E) Wahed platelets were plated onto fibrinogen-coated coverslips and after 1 h stained with phalloidin and DAPI and observed under a Zeiss inverted microscope (Axiovision Observer.z1; 40×/NA 0.6). The pictures were captured by a Zeiss AxioCam MRm camera using the microscope operating and image analysis software ZEN 2.6. (F) Washed platelets from WT mice were labeled with calcein acetoxymethyl ester (10 μM) for 30 min and placed onto fibrinogen-coated wells in a 96-well plate. Platelets were then incubated with and without F 2 -TXA2 at the indicated concentrations for 30 min, washed with PBS and the bound platelets were lysed with lysis buffer and the fluorescence intensity was measured at 494 excitation and 517 emission ( n = 3). (G) PRP from WT mice treated with and without F 2 -TXA2 at the indicated concentrations was subjected to aggregation assay in an aggregometer ( n = 3). (H) Washed platelets from WT and 12/15-LOX −/− mice were subjected adhesion assay as shown in panel F ( n = 3). (I) PRP from WT and 12/15-LOX −/− mice with and without the indicated treatments were subjected to aggregation assay in an aggregometer ( n = 3). (J) Washed platelets from WT and 12/15-LOX −/− mice were incubated with and without F 2 -TXA2 for 30 min and plated onto fibrinogen-coated coverslips for 1 h. Platelets were then fixed, permeabilized, and stained with phalloidin to visualize F-actin, and pictures were captured. (K and L) Platelets from WT and 12/15-LOX −/− mice were incubated with and without F 2 -TXA2 (1 μM) for indicated time periods, and RNA and protein extracts were prepared and analyzed by qRT-PCR (K) and western blotting (L) for 12-LOX, 12/15-LOX and β-actin mRNA and protein levels using their specific primers or antibodies, respectively ( n = 3). (M) Platelets from WT and 12/15-LOX −/− mice were treated with and without F 2 -TXA2 for 30 min, and protein extracts were prepared and analyzed by western blotting for the levels of phospho and total eIF4E and 4EBP1 using their specific antibodies ( n = 3). (N) All the conditions were the same as in panel M except that the extracts were immunoprecipitated with anti-4EBP1 antibody, and the immunocomplexes were analyzed by western blotting for eIF4E and normalized for 4EBP1. The input protein was analyzed for β-actin levels. (O and P) Platelets from WT mice were incubated with and without F 2 -TXA2 in the presence and absence of rapamycin (100 nM) or torin1 (100 nM) for 30 min, and protein extracts were analyzed by western blotting for p4EBP1, 4EBP1, 12/15-LOX, and β-actin levels using their specific antibodies ( n = 3). (Q) Platelets from WT mice and 12/15-LOX −/− mice were assessed for 12(S)-HETE levels using a kit from Cayman ( n = 7). (R–W) Platelets from WT mice and 12/15-LOX −/− mice were treated with and without U46619 (1 μM) or ADP (40 μM) for 30 min and 12(S)-HETE levels were measured (R and U) ( n = 7) or subjected to adhesion assay (S and V) ( n = 3) or aggregation assay (T and W) ( n = 3). All data are presented as mean ± SD and analyzed by paired Student’s t test. ∗ p < 0.01 versus WT mice or control; # p < 0.01 versus F 2 -TXA2 or WT + F 2 -TXA2 or U46619. Scale bars: 10 μm in (E) and (J).

Article Snippet: Anti-eIF4E antibody , Santa Cruz Biotechnology , sc-9976.

Techniques: Activation Assay, Coagulation, Clinical Proteomics, Incubation, Staining, Inverted Microscopy, Microscopy, Software, Labeling, Lysis, Fluorescence, Cell Adhesion Assay, Quantitative RT-PCR, Western Blot, Immunoprecipitation, Control

Figure 3. eIF4E is required for MCT-1 interaction with the cap complex. The eIF4E was immunodepleted from the reticulocyte lysate containing the MCT-1 and MCT-1 deletion proteins. A, Western blot with eIF4E antibody of the lysate before and after eIF4E depletion as well as the depleted eIF4E. B, the cap binding assay was done as in Fig. 2B, but also with the eIF4E-depleted extract (left). Right, 5% of the input MCT-1 and deletion proteins. C, MCT-1 and DENR sediment with the translation initiation complex. Transiently transfected 293HEK cells were used for polysome preparation as described. Fractions 1 to 3 are typically completely devoid of ribosome components and contain multifactor complex. Representative polysome distribution profile (top). Representative Western blot analysis with antibodies against eIF2a, eIF4E, Myc-DENR, V5-MCT-1, h-actin, and rS6p (bottom).

Journal: Cancer Research

Article Title: MCT-1 Protein Interacts with the Cap Complex and Modulates Messenger RNA Translational Profiles

doi: 10.1158/0008-5472.can-06-1999

Figure Lengend Snippet: Figure 3. eIF4E is required for MCT-1 interaction with the cap complex. The eIF4E was immunodepleted from the reticulocyte lysate containing the MCT-1 and MCT-1 deletion proteins. A, Western blot with eIF4E antibody of the lysate before and after eIF4E depletion as well as the depleted eIF4E. B, the cap binding assay was done as in Fig. 2B, but also with the eIF4E-depleted extract (left). Right, 5% of the input MCT-1 and deletion proteins. C, MCT-1 and DENR sediment with the translation initiation complex. Transiently transfected 293HEK cells were used for polysome preparation as described. Fractions 1 to 3 are typically completely devoid of ribosome components and contain multifactor complex. Representative polysome distribution profile (top). Representative Western blot analysis with antibodies against eIF2a, eIF4E, Myc-DENR, V5-MCT-1, h-actin, and rS6p (bottom).

Article Snippet: Half of this reaction (50 AL) was used for overnight depletion of eIF4E by using 4 Ag of eIF4E antibody (Santa Cruz Biotechnology), 20 AL of protein A/G agarose beads and protease inhibitor.

Techniques: Western Blot, Binding Assay, Transfection

Figure 6. Proposed model for role of MCT-1 in translation. MCT-1 bound to DENR binds to the cap complex either directly or indirectly through interaction with eIF4E with enhanced translation initiation by scanning and recognition of the initiation codon. MCT-1 and DENR might also recruit additional translation factors to the translation initiation complex.

Journal: Cancer Research

Article Title: MCT-1 Protein Interacts with the Cap Complex and Modulates Messenger RNA Translational Profiles

doi: 10.1158/0008-5472.can-06-1999

Figure Lengend Snippet: Figure 6. Proposed model for role of MCT-1 in translation. MCT-1 bound to DENR binds to the cap complex either directly or indirectly through interaction with eIF4E with enhanced translation initiation by scanning and recognition of the initiation codon. MCT-1 and DENR might also recruit additional translation factors to the translation initiation complex.

Article Snippet: Half of this reaction (50 AL) was used for overnight depletion of eIF4E by using 4 Ag of eIF4E antibody (Santa Cruz Biotechnology), 20 AL of protein A/G agarose beads and protease inhibitor.

Techniques: